Pfizer Limited — Others, 29-06-2025: Shareholders meeting

Pfizer Limited has announced a board meeting on July 21, 2025, to approve the financial results for the quarter and half-year and conduct the 74th Annual General Meeting via video conferencing. The Board has proposed a total dividend of ₹165 per equity share of ₹10 each, comprising a final dividend of ₹35, a special dividend of ₹100 celebrating 75 years in India, and an additional ₹30 special dividend related to the gain from sale of leasehold land and building at Thane. This dividend amounts to approximately ₹755 crore, pending shareholder approval. The company reported sales of ₹2,128.36 crore, a 2.3% increase over the previous year, and a profit before tax of ₹1,016.09 crore, up 36.2%, aided by a net gain of ₹172.81 crore from the sale of the Thane property. The Board reiterated its commitment to delivering shareholder value amid growth in key brands like Eliquis, Prevenar 13, Zavicefta, and Meronem. Sustainability initiatives, including solar power usage at the Goa plant covering 53% of its electricity needs and a 31.6% reduction in greenhouse gas emissions, continue to advance. Corporate Social Responsibility efforts remain focused on healthcare innovation, antimicrobial resistance, cancer care, and community development projects. The company maintains strong corporate governance with seven Directors on its Board, including three Independent Directors and key leadership appointments in strategy and operations. Audit, risk management, and CSR committees are active, with statutory auditors B S R & Co. LLP continuing their term; appointments of cost and secretarial auditors are proposed for ratification. Financial statements comply with Indian Accounting Standards and reflect adequate internal controls. Tax litigations and statutory disputes exist but are largely considered manageable based on legal opinions. The company’s equity share capital stands at ₹45.75 crore with strong promoter and institutional holdings. Remote e-voting and virtual AGM facilities are arranged for shareholders with detailed procedures outlined for participation and voting.